The discovery of novel counteractive pharmaceuticals, which have recently generated much interest, has played a significant role in the development of drugs derived from herbal medicines or botanical sources. Paederia foetida (P. foetida) is one such example of a role in both traditional and traditional medicine. Owing to its popularity in folk medicine, it has been the subject of intense pharmacological and chemical studies for the last 30 years. They are locally known as "Gandhavadulia" or "GandhaPrasarini" (English name "skunkvine") and belong to the family Rubiaceae. This plant has a broad range of applications in the treatment of several illnesses, including anti-inflammatory, antinociceptive, antitussive, thrombolytic, antidiabetic, antihyperlipidaemic, antioxidant, nephroprotective, anti-inflammatory, hepatoprotective, anthelmintic, and antidiarrheal effects. Additionally, it contains a variety of phytochemicals, such as asperuloside, paederosidic acid, sitosterols, campesterol, lignans, alkaloids, volatile oils, iridoids, methylindooxy substances, stigmasterol, tannins, triterpenoids, ellagic acid, ursolic acid, epifriedelinol, and phenolic compounds. Recently, mounting data on numerous active ingredients have indicated that they may be beneficial for spermatogenesis, wound healing, inflammatory illnesses, and cancer. This review describes the phytochemistry and mechanisms of action of these pharmacological effects and provides insights into potential pharmacological targets. These results highlight the need for additional studies on this medicinal plant and the investigation of new counteractive medications to determine their mode of action before use in healthcare.

Ursolic acid (UA) is a pentacyclic triterpenoid that is widely distributed in plants and has recently attracted much attention because of its numerous pharmacological characteristics and medicinal uses. This review presents a detailed synopsis of the pharmacological actions, molecular mechanisms, and therapeutic possibilities of ursolic acid. Ursolic acid exhibits various biological properties, including antioxidant, anti-inflammatory, anticancer, antidiabetic, anti-obesity, antiseptic, liver-protective, neuroprotective, and cardioprotective effects. These effects are mediated through multiple molecular pathways, including the modulation of various signaling pathways, inhibition of enzymes, regulation of gene expression, and interaction with cellular receptors. Notably, the anticancer properties of ursolic acid have been thoroughly investigated, and data indicate that it can effectively prevent cancer cells from proliferating, trigger apoptosis, reduce metastasis, and make cancer cells more vulnerable to radiotherapy. In addition, ursolic acid has demonstrated potential in treating obesity and diabetes, which are examples of metabolic disorders characterized by enhanced insulin sensitivity, reduced body fat, and dyslipidemia. Ursolic acid represents a prospective option for developing innovative therapeutic drugs to prevent and treat many diseases due to its pleiotropic properties. Nevertheless, additional preclinical and clinical research is necessary to clarify its safety profile, optimal dosage, and potential drug interactions. Enhancing bioavailability and targeted delivery may further improve therapeutic efficacy.

The therapeutic efficacy of various phytoconstituents is improved by the use of phytosome, innovative drug delivery methods based on phytochemicals, by enhancing their absorption, bioavailability, and therapeutic availability. This exceedingly complex type of herbal formulation contains the active phytoconstituent of the herbal extract and is joined by a phospholipid molecule. They also operate as vesicular systems for a wide range of fascinating and important phytoactives. The phytosome method produces startlingly tiny spheres or cells, which is advantageous in keeping active phytochemical contents from being destroyed by the stomach environment. Phytosome also produce pharmacokinetic and pharmacodynamic effects that are more potent than those of conventional herbal extracts. Phytosome demonstrated increased pharmacokinetics and pharmacodynamic response when compared to conventional botanical extracts. Through the use of phytosome technology, the bioavailability of several of the most widely used herbal extracts, such as milk thistle, Ginkgo biloba, grape seed, green tea, hawthorn, ginseng, etc., has been improved. These drug-phospholipid complexes can be produced as a liquid solution, suspension, emulsion, syrup, lotion, gel, cream, tablet, capsule, powder, or granule. The purpose of this review is to emphasize the application of how the phytosome technology has helped to improve the bioavailability and absorbance of the cosmeceuticals.